Christopher Haig, Efemoral Medical - Drug-Eluting Bioresorbable Scaffold | LSI USA '24

Efemoral Medical is a clinical stage startup developing a next-generation drug-eluting bioresorbable scaffold for the treatment of PAD.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Christopher Haig
Christopher Haig
Efemoral Medical